Polymer free Sirolimus

Eluting Stent System

Deals with the HARD facts with current DES

  • ABLUMINAL COATING

    Drug is coated on the abluminal side only. Leading to mono directional drug release & less systemic exposure of drug which leads to faster healing

  • FUSION COATING

    Drug is coated on stent as well as exposed parts of balloon & coated on the proximal and distal ends. Helps to address the entire disease area of lesion and address focal restenosis and edge restenosis.

  • POLYMER FREE NANO CARRIER DRUG DELIVERY

    Designed for acute as well as sustained drug transfer in arterial wall – leading to less chronic inflammation and improved vascular healing.

  • POLYMER FREE COATING

    Proposed the shorter DAPT which helps to reduced bleeding risk in patients with high bleeding risk

Nanoactive Technology

Advantages of Nanoactive Technology

  • Reduces drug dose

  • Effective drug transfer to the deepest layer of the vessel

  • Protect drug by encapsulation- reduced in-transit drug loss

  • Better in-tissue bioavailability of drug

Clinical Programs

Sr. No Study Name Type of Study Target Patients Country Principal Investigator
Sr. No:  01 Study Name:  NANOACTIVE FIM Type of Study:  Prospective, Non-randomized, Multi Center Target Patients:  86 Patients Country:  India Principal Investigator:  Dr. Ashok Seth
Sr. No:  02 Study Name:  NANOACTIVE PMS Type of Study:  Prospective, , Non-randomized, Multi Center Target Patients:  90 Patients Country:  India Principal Investigator:  Dr. Anil Potdar
“Confidence through evidence”
Get in Touch
Download Clinical Update